
Franklin L Chen MD
Hematologic Oncology
Clinical Physician Executive, Department of Hematology Oncology, Transplant Cellular Therapy Section, Novant Health Cancer Institute
Join to View Full Profile
3333 Silas Creek PkwyWinston-Salem, NC 27103
Phone+1 336-277-8800
Fax+1 336-277-8850
Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2006 - 2009
UPMC Medical EducationResidency, Internal Medicine, 2003 - 2006
Icahn School of Medicine at Mount SinaiClass of 2003
Certifications & Licensure
NC State Medical License 2006 - 2026
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Clinical Trials
- A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread Start of enrollment: 2014 Mar 12
- Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL Start of enrollment: 2022 Jan 01
Publications & Presentations
PubMed
- 1 citationsInflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer.Ming Lei, Michael J Overman, Jin Yao, Thierry André, Sara Lonardi
Nature Communications. 2025-10-06 - 2 citationsThe effect of mobilizing large numbers of CD34 + cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation.Jan S Moreb, Lori Lantos, Franklin Chen, Kathleen Elliott, James Dugan
Transfusion and Apheresis Science. 2023-12-01 - 19 citationsEfficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study.Claire F. Verschraegen, Guy Jerusalem, Edward F. McClay, Nicholas Iannotti, Charles H. Redfern
Journal for Immunotherapy of Cancer. 2020-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









